Interleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitisFrancesco Ciccia(University of Palermo), G Triolo(University of Palermo)Arthritis & RheumatismDecember 27, 201110.1002/art.34355Cited by 128SaveCiteExport RISWatch citationsRelated PapersRituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren’s syndrome|Lara D. Veeken|2014|51Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity|Lara D. Veeken|2014|15